SML2020
阿曲生坦 盐酸盐
≥98% (HPLC)
同義詞:
2R-（4-甲氧基苯基）-4S-（1,3-苯并二恶唑-5-基）-1-（N，N-二（正丁基）氨基羰基甲基）-吡咯烷-3R-羧酸盐酸盐, ABT-627盐酸盐, 盐酸A-147627, （2R，3R，4S）-4-（1,3-苯并二恶唑-5-基）-1- [2-（二丁基氨基）-2-氧乙基] -2-（4-甲氧基苯基）-3-吡咯烷羧酸盐酸盐
登入查看組織和合約定價
全部照片(1)
About This Item
經驗公式（希爾表示法）:
C29H38N2O6 · HCl
CAS號碼:
分子量：:
547.08
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.77
推薦產品
![5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-6-yl 4-methylbenzenesulfonate AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/271/040/2c31c3ad-5d79-4a34-b334-e3ff6645d365/640/2c31c3ad-5d79-4a34-b334-e3ff6645d365.png)
化驗
≥98% (HPLC)
形狀
powder
儲存條件
desiccated
顏色
white to beige
溶解度
DMSO: 2 mg/mL, clear
儲存溫度
2-8°C
SMILES 字串
[H]Cl.CCCCN(CCCC)C(CN1C[C@H](C2=CC=C(OCO3)C3=C2)[C@@H](C(O)=O)[C@@H]1C4=CC=C(OC)C=C4)=O
InChI
1S/C29H38N2O6.ClH/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20;/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34);1H/t23-,27-,28+;/m1./s1
InChI 密鑰
IJFUJIFSUKPWCZ-SQMFDTLJSA-N
一般說明
阿曲生坦也已用于治疗心血管疾病。
生化／生理作用
阿曲生坦是一种选择性内皮素 ETA 受体拮抗剂，ETA 的 IC50 为 0.2 nM，而 ETB 受体的 IC50 为 190 nM。它阻断内皮素诱导的细胞增殖，已被研究作为前列腺癌的一种潜在疗法，最近又被用于糖尿病肾病的疗法。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Carmen De Miguel et al.
Scientific reports, 7, 43152-43152 (2017-02-24)
Endothelin-1 (ET-1) promotes renal damage during cardiovascular disease; yet, the molecular mechanisms involved remain unknown. Endoplasmic reticulum (ER) stress, triggered by unfolded protein accumulation in the ER, contributes to apoptosis and organ injury. These studies aimed to determine whether the
Margien G S Boels et al.
Diabetes, 65(8), 2429-2439 (2016-05-22)
Atrasentan, a selective endothelin A receptor antagonist, has been shown to reduce albuminuria in type 2 diabetes. We previously showed that the structural integrity of a glomerular endothelial glycocalyx is required to prevent albuminuria. Therefore we tested the potential of
Determination of atrasentan by high performance liquid chromatography with fluorescence detection in human plasma.
Bryan P D, et al.
Biomedical Chromatography, 15(8), 525-533 (2001)
Chunhua Jin et al.
The Journal of pharmacology and experimental therapeutics, 351(2), 467-473 (2014-09-06)
Experiments determined whether the combination of endothelin A (ETA) receptor antagonist [ABT-627, atrasentan; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid] and a thiazide diuretic (chlorthalidone) would be more effective at lowering blood pressure and reducing renal injury in a rodent model of metabolic syndrome compared
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務